Restricted accessResearch articleFirst published online 1984-5
Comparison of Topical Treatment with Desoxymethasone Solution 0·25% with Salicylic Acid 1% and Betamethasone Valerate Solution 0·1% in Patients with Psoriasis of the Scalp
A new preparation for treatment of psoriasis of the scalp, containing desoxymethasone 0·25%, salicylic acid 1% and polyol-fatty esters in ethanolic solution (Ibaril®) was tested in patients with psoriasis of the scalp. In a double-blind study comprising forty patients there was a significant difference in favour of this solution in comparison with betamethasone valerate solution, 0·1% (Betnovat®) after 2 weeks of treatment.
Get full access to this article
View all access options for this article.
References
1.
BjörnbergAHellgrenL (1975) Vergleich zweier Steroid-Zubereitungen bei Psoriasis und Ekzem. Zeitschrift für Hautkrankheiten50, Suppl. 2, 13.
2.
BossongWGrimmerH (1975) Zur Anwendung von Topisoion bei Dermatosen. Zeitschrift für Hautkrankheiten50, Suppl. 2, 7.
3.
FedrikssonT (1979) A double-blind clinical trial of desoxymethasone fatty ointment versus fluocinolone acetonide ointment in psoriasis. Current Therapeutic Research, 25, 809.
4.
KuokkanenK (1977) Comparison of 0·25% desoxymethasone ointment with 0·05% fluocinonide ointment in psoriasis. Current Medical Research and Opinion4, 703.
5.
LassusA (1977) Local treatment of psoriasis with desoxymethasone and betamethasone 17, 21-dipropionate: a double-blind comparison. Current Medical Research and Opinion4, 650.
6.
LundellE (1975) A double-blind trial of a new topical steroid formulation containing desoxymethasone against fluocinolonacetonid cream. Zeitschrift für Hautkrankheiten50, Suppl. 2, 17.
7.
NairB KNairC H K (1975) Clinical evaluation of desoxymethasone in treatment of dermatoses and psoriasis. International Journal of Dermatology14, 277.
8.
SavinR C (1978) Desoxymethasone — a new topical corticosteroid. Short- and long-term experiences. Cutis21, 403.
9.
Wallis-Roberts (1964) Statistics: A New Approach, 19, 4, Methuen, London.
